ALLO Competitors & Alternatives
Compare Allogene Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALLO
Main Stock$1.93
Tradestie Score
44
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+339.6%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$16.90
|
$726.21M | 7.6 | 52 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$22.71
|
$718.62M | - | 61 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.67
|
$715.25M | - | 61 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$146.03
|
$699.30M | - | 61 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.34
|
$688.47M | - | 56 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.10
|
$670.30M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.34
|
$665.30M | - | 59 | Compare |
|
ANL
ANL
|
$9.24
|
$635.61M | - | 49 | Compare |
More ALLO Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry